Pterygopalatine Ganglion: Anatomy, Function, and Pain Blocks

The pterygopalatine ganglion is a small cluster of nerve cells tucked deep behind your cheekbone that acts as a relay station for parasympathetic signals traveling to your eyes, nose, palate, and brain’s blood vessels. Despite being only a few millimeters across, it plays an outsized role in tear production, nasal secretion, cerebral blood flow regulation, and several types of head pain. Clinicians and researchers also call it the sphenopalatine ganglion, and it has become a surprisingly active target for treatments ranging from migraine relief to experimental stroke therapy.

Where It Sits and What It Looks Like

The ganglion lives inside the pterygopalatine fossa, a small, pyramid-shaped cavity behind the maxillary sinus and below the eye socket. Cadaver studies using precise measurements show the ganglion consistently sits close to the posterior wall of the fossa (less than a millimeter away) and near the top, with greater distances separating it from the front and inner walls of the cavity.¹ That rear-and-upper position matters for surgeons and interventionalists who need to reach it with a needle or catheter. The fossa itself divides into an anterior compartment rich in blood vessels and a posterior compartment dominated by nerves, and the ganglion consistently occupies the posterior one.

What most anatomy textbooks do not mention is that the ganglion’s shape varies quite a bit from person to person. A morphological study of human specimens identified four distinct configurations. In roughly half of people, the ganglion appears as a single body with the vidian nerve entering near the top. But in about 30% of people, the ganglion is actually partitioned into two separate components, and in the remaining cases the vidian nerve connects at the bottom rather than the top.² Adding to the complexity, histochemical analysis has revealed scattered clusters of tiny nerve cells near the main ganglion, called dispersed pterygopalatine microganglia. The upshot is that describing the ganglion as a single, uniform structure is an oversimplification. This variability is worth knowing because it can affect how well any procedure aimed at the ganglion actually reaches it.

The Wiring Diagram

Three types of nerve fibers pass through the pterygopalatine ganglion, but only parasympathetic fibers actually synapse there, meaning they hand off their signals to new nerve cells within the ganglion. Sympathetic fibers and sensory fibers pass straight through without stopping, like cars using an interchange without exiting.

The parasympathetic input arrives via the vidian nerve, which itself is formed by the merging of two smaller nerves. One is the greater petrosal nerve, a branch of the facial nerve that carries parasympathetic fibers originating in the brainstem.³ The other is the deep petrosal nerve, which carries sympathetic fibers from the carotid plexus. When the two merge into the vidian nerve and reach the ganglion, the parasympathetic fibers synapse onto new neurons whose branches then fan out to the lacrimal gland, the mucous glands of the nose and palate, and blood vessels in the brain. The sympathetic fibers simply pass through to the same destinations without switching neurons.

Sensory branches from the maxillary division of the trigeminal nerve also traverse the ganglion, carrying pain and touch information from the midface. This convergence of parasympathetic, sympathetic, and sensory fibers in one compact hub is what gives the ganglion its clinical significance: it is a chokepoint where you can modulate tear flow, nasal congestion, blood vessel diameter, and pain signaling all at once.

Tears and the Lacrimal Gland

One of the ganglion’s most concrete jobs is triggering tear production. After synapsing in the ganglion, postganglionic parasympathetic fibers travel toward the lacrimal gland in the upper outer part of the eye socket. A detailed tracing study in human cadavers revealed that the route these fibers take is not what textbooks long assumed. Rather than hitching a ride along the zygomatic and lacrimal branches of the trigeminal nerve, the secretomotor fibers leave the ganglion as orbital branches, pass along the side wall of the orbit, join a nerve plexus at the back of the eye socket, and send about five to ten fine branches directly into the lacrimal gland.⁴ That finding has practical consequences: surgical procedures that cut ophthalmic nerve branches to reduce excessive tearing rest on an outdated assumption and are unlikely to work as intended.

Animal studies have confirmed that cutting the parasympathetic supply from the ganglion to the lacrimal gland causes tear secretion to drop immediately and stay low chronically, eventually leading to gland shrinkage and structural damage. Importantly, interrupting the sympathetic supply alone did not produce these effects, pointing to the parasympathetic fibers as the critical drivers of tear production.⁵ The clearest human illustration of this relationship comes from familial dysautonomia, a rare genetic disorder in which the sphenopalatine ganglia contain less than one-fifth the normal volume and drastically fewer neurons. Patients with this condition characteristically cannot produce overflow tears.⁶

Blood Flow in the Brain

Perhaps the most surprising function of this little ganglion is its influence on cerebral blood vessels. Postganglionic fibers from the ganglion reach the arteries of the anterior brain circulation and release nitric oxide, a powerful vasodilator. In animal experiments, electrically stimulating the ganglion causes the brain’s arteries on the same side to widen measurably. When researchers blocked nitric oxide production with a chemical inhibitor, the vasodilation disappeared, confirming nitric oxide as the key mediator.⁷ Complementary work showed that deliberately damaging the ganglion on one side abolished the normal relaxation response in the brain and retinal arteries on that side, and in some cases reversed it to contraction.⁸

Direct measurements of cerebral blood flow in rats found that stimulating either the preganglionic input to the ganglion or the ganglionic fibers themselves increased blood flow by roughly 40 to 60 percent, with no change in systemic blood pressure or blood carbon dioxide levels. When the nerve fibers running from the ganglion to the brain were cut, stimulation no longer had any effect, proving the blood flow boost was mediated through those specific parasympathetic projections rather than through some systemic circulatory change.⁹

Experimental Stroke Treatment

The ganglion’s ability to boost cerebral blood flow on demand has made it a target for stroke research. The idea is straightforward: during an ischemic stroke, a blocked artery starves brain tissue of blood. If stimulating the ganglion could open up collateral pathways and increase blood flow around the blockage, some of that tissue might be rescued. A review of preclinical and early human work identified four distinct ways ganglion stimulation could help after a stroke: it widens collateral blood vessels through nitric oxide and acetylcholine release; it stabilizes the blood-brain barrier in a way that depends on stimulation intensity, reducing swelling; it activates anti-inflammatory and anti-cell-death pathways through the central cholinergic system; and it promotes brain plasticity and new neuron growth.¹⁰

A device called the Ischemic Stroke System was developed specifically to deliver electrical stimulation to the ganglion during acute stroke. A feasibility trial in humans evaluated both the safety and the potential benefit of placing a small stimulator near the ganglion in stroke patients. In rat models used to guide the human trial design, ganglion stimulation increased cerebral blood flow, reduced the volume of dead brain tissue, protected the blood-brain barrier, and improved neurological outcomes.¹¹ This line of research is still in its early stages, and it is fair to say the results in humans have been less dramatic than in animal models. But the underlying biology is sound enough that clinical trials continue to refine who might benefit, how soon after a stroke the stimulation should begin, and what frequency and intensity work best.

Cluster Headache and the Trigeminal-Autonomic Reflex

If you have ever seen someone in the grip of a cluster headache, you have witnessed the pterygopalatine ganglion in overdrive. Cluster headache attacks bring extreme one-sided head pain along with autonomic symptoms on the same side: a watering eye, a runny or congested nose, facial sweating, and a drooping eyelid. These symptoms reflect activation of the trigeminal-autonomic reflex, and the ganglion sits squarely in the middle of that reflex arc.¹²

An illuminating experiment tested what happens when you deliberately stimulate the ganglion in cluster headache patients. Low-frequency stimulation actually provoked cluster-like attacks in half of the participants, reproducing the pain and autonomic symptoms that define the condition. Strikingly, switching to high-frequency stimulation then aborted those same attacks successfully.¹³ That two-way relationship, where the ganglion can both trigger and terminate attacks depending on stimulation parameters, underscores how central it is to the disorder’s biology and why it has become a leading target for neuromodulation devices.

Blocking the Ganglion for Headaches and Pain

A sphenopalatine ganglion block involves applying a local anesthetic, usually lidocaine, to the area around the ganglion. The simplest version is transnasal: a thin catheter is threaded into the nostril and advanced to the back of the nasal cavity, where the ganglion lies just behind the mucous membrane. No needles through the skin are required. A retrospective case series evaluating this approach with a device called the Sphenocath found rapid headache relief within 15 minutes, sustained improvement at two hours, and lasting effects at 24 hours in most patients treated for acute migraine.¹⁴

A systematic review examining the full range of ganglion-targeting procedures found the strongest evidence for cluster headache, but also noted benefits for trigeminal neuralgia, migraine, and post-surgical pain reduction after sinus operations. The review covered three main approaches: blocks using local anesthetic, radiofrequency ablation that partially destroys the ganglion’s nerve cells with heat, and implanted neurostimulators that deliver ongoing electrical stimulation.¹⁵ Each approach sits on a different point of the invasiveness spectrum. A transnasal block with lidocaine can be done in an office visit and wears off in hours. Radiofrequency ablation requires image guidance and produces longer-lasting but sometimes unpredictable results. Implanted neurostimulators require a surgical procedure to place a small device near the ganglion, but they give the patient on-demand control over stimulation, which can abort individual headache attacks.

Post-Dural Puncture Headache

Anyone who has had a spinal tap or an epidural for labor knows there is a small risk of developing a severe headache afterward. Post-dural puncture headache happens when cerebrospinal fluid leaks through the puncture hole in the dural membrane, causing low pressure around the brain. It typically worsens when you sit up and improves when you lie down. The traditional rescue treatment is an epidural blood patch, where a small amount of the patient’s own blood is injected into the epidural space to seal the leak. While effective, blood patches are invasive and carry their own risks.

Ganglion blocks have emerged as an alternative. A narrative review of the technique describes how applying local anesthetic to the ganglion can reduce the parasympathetic-driven vasodilation in the brain that contributes to the headache, offering relief without another epidural needle.¹⁶ A randomized controlled study comparing the block to conservative management found that patients who received the block consumed roughly a third as much pain medication, had significantly lower headache scores for about 54 hours, and reported better overall satisfaction. None of the patients in the block group required a blood patch, while one patient in the control group did.¹⁷

The approach has gained particular interest in obstetric settings, where post-dural puncture headaches after cesarean sections can be debilitating for new mothers who need to care for their babies. A case report and literature review described a woman with a stubborn post-dural puncture headache following cesarean delivery who got immediate pain relief from a ganglion block after other measures had failed.¹⁸ The evidence base is still growing, and the block is generally considered a bridge or alternative rather than a full replacement for blood patches in severe cases.

Nasal Congestion and Allergic Rhinitis

Because the ganglion’s postganglionic fibers directly supply the mucous glands and blood vessels of the nasal lining, it is no surprise that it plays a role in allergic rhinitis. When the parasympathetic outflow through the ganglion ramps up, nasal glands secrete more mucus and the mucosal blood vessels dilate, producing the familiar stuffy, runny nose. Targeting the ganglion to dampen that response is a logical therapeutic strategy.

One case report documented a child with allergic rhinitis treated with pulsed radiofrequency neuromodulation directed at the ganglion under ultrasound guidance. Over a 24-week follow-up, the child’s symptoms improved markedly, with resolution of nighttime mouth breathing and reduced frequency of nasal congestion, tearing, and eye redness.¹⁹ Pulsed radiofrequency is gentler than conventional radiofrequency ablation; it delivers short bursts of electrical energy that modulate nerve activity without destroying tissue. This matters in children, where permanent nerve damage would be a harder trade-off to accept.

Reaching the Ganglion Surgically

For surgeons removing tumors or other lesions from the pterygopalatine fossa, access has traditionally been difficult because the space is deep, narrow, and surrounded by critical structures. An anatomical study evaluating the endoscopic endonasal approach, where a camera and instruments are inserted through the nostril, found it provided wide exposure of the fossa’s contents and allowed visualization of surrounding areas as well. The study concluded the approach is safe for removing lesions in this region, and it has the advantage of leaving no external scars.²⁰ This endoscopic route has become the preferred method at many centers for dealing with juvenile nasopharyngeal angiofibromas and other benign tumors that grow in or near the fossa.

Understanding the ganglion’s precise position within the fossa is especially important for percutaneous approaches, where a needle is advanced through the cheek toward the ganglion. The quantitative mapping showing the ganglion’s consistent location near the posterior and superior walls of the fossa gives interventionalists a reliable target zone, while the identification of a relatively blood-vessel-free corridor extending backward from the ganglion toward the infratemporal fossa offers a safer trajectory for needle placement.²¹

How the Ganglion Develops Before Birth

During embryonic development, the pterygopalatine ganglion does not start as an isolated structure. A study of human embryos and fetuses between six and fifteen weeks of development found that at six weeks, the ganglion and the nearby otic ganglion (a different parasympathetic relay station involved in salivation) exist as a single undifferentiated cell mass, intertwined with the developing sphenoid bone. By seven weeks, a bony projection between them shrinks and the two ganglia separate, each taking up its adult position. This intimate early relationship with the growing skull base explains why the ganglion ends up in such a confined, bony-walled space in adults. It did not migrate there; the bones grew up around it.

The morphological variation seen in adults, where some people have a neatly single ganglion and others have a partitioned one, likely traces back to individual differences in how completely the original cell mass consolidates during this developmental window. Whether the ganglion ends up as one body or two, and where exactly the vidian nerve plugs in, appears to be set by the seventh or eighth week of fetal life.

Familial Dysautonomia and What It Reveals

Familial dysautonomia is a rare inherited disorder affecting the autonomic and sensory nervous systems. Patients have trouble regulating blood pressure, body temperature, and swallowing, among many other problems. One of the condition’s hallmark features is alacrima, the inability to produce emotional tears. Quantitative examination of the sphenopalatine ganglia in patients with the disorder found that the ganglia contained only about 1,500 neurons on average, compared to roughly 56,500 in healthy controls.²² The ganglion volumes were less than a fifth of normal. This dramatic neuron loss directly accounts for the absence of tears: without adequate parasympathetic relay neurons in the ganglion, the signal from the brainstem never reaches the lacrimal gland in sufficient strength to trigger secretion. In a sense, familial dysautonomia acts as a natural experiment demonstrating just how dependent tear production is on having a functioning pterygopalatine ganglion.